Due diligence: Curbs on surrogate advertising must avoid regulatory overreach

What happened: Maharashtra FDA enforcement on celebrity-endorsed tobacco-adjacent surrogate advertising

Maharashtra Food and Drug Administration Commissioner Tukaram Mundhe has taken enforcement action against celebrity-endorsed surrogate advertising connected to tobacco interests. The enforcement is aimed at advertisements where a brand appears to trade on an independent identity, but the brand’s market presence is presented as effectively tied to tobacco through endorsement associations.

The enforcement focus includes the brand Vimal Elaichi, which has been endorsed by prominent film personalities. The core regulatory concern is that the endorsed brand does not operate as a separate market entity and functions as a proxy for tobacco promotion.

Background and earlier position: surrogate advertising proof and regulatory practice

Surrogate advertising in tobacco control generally refers to advertising that indirectly promotes tobacco products by using brand names, trademarks, or brand imagery that remain closely connected to tobacco, even if the advertisement does not directly advertise cigarettes or other tobacco products.

The opinion supports the view that current advertising conditions create an asymmetry: the party persuading consumers often faces less economic downside for the persuasive act, while public health protections can be weak. Under such conditions, regulators may interpret certain endorsements as unfair trade practices with serious consumer-health consequences when they operate like surrogate tobacco promotion.